PharmaEssentia Reports April 2026 Revenue of NT$2.064 Billion (Up 68.3% YoY)
PharmaEssentia (6446) announced its revenue for April 2026, reaching NT$2.064 billion, a significant 68.3% increase compared to the same period last year.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 11:13 (3h 13m after Collected)
PharmaEssentia, a company in the biotechnology and healthcare sector, reported its financial results for April 2026. The company's revenue for the month was NT$2.064179 billion (approximately NT$2.064 billion), representing a substantial year-over-year increase of 68.3%.
FAQ
What is PharmaEssentia's stock code?
PharmaEssentia's stock code is 6446.
What industry does PharmaEssentia belong to?
PharmaEssentia belongs to the biotechnology and healthcare industry.
What was PharmaEssentia's revenue in April 2026?
PharmaEssentia's revenue in April 2026 was NT$2.064 billion.
How did PharmaEssentia's revenue change year-over-year in April 2026?
PharmaEssentia's revenue increased by 68.3% year-over-year in April 2026.